Clinics in Thailand primarily use Mesenchymal Stem Cells (MSCs) sourced from umbilical cord tissue or adipose fat to treat Parkinson's disease. These allogeneic cells are selected for their rapid multiplication and low immunogenicity, delivered via intravenous infusion or intrathecal injection to bypass the blood-brain barrier.
- Cell sources: MSCs are harvested from umbilical cord tissue, cord blood, or patient fat tissue.
- Administration methods: Doctors use intravenous (IV) infusion or intrathecal injections to target the nervous system.
- Lab standards: Top facilities use AABB-certified laboratories or GMP-certified standards for processing cellular products.
- Neurological oversight: Treatment plans are often overseen by neurosurgeons like Dr. Pongwat Polpong at EDNA Wellness.
Bookimed Expert Insight: While many clinics offer general regenerative therapy, specific Parkinson's protocols in Thailand often include 40,000,000 to 100,000,000 cells per session. Centers like ID Clinic Bangkok provide these specific cell counts within all-inclusive packages, which helps patients compare the actual dosage value across different providers.
Patient Consensus: Patients emphasize verifying the exact cellular product, as marketing terms like live cell therapy or rejuvenation vary. They often suggest confirming the delivery method beforehand since intrathecal administration is more invasive than standard IV drips.